|
Bernal E, Verdú JM, Vera F, Martinez O, Bravo J, Galera C, Muñoz A, Garcia E, Serrano J, Perez A, Vera C, Marín I, Cano A. Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19726. doi: 10.7448/IAS.17.4.19726. PubMed PMID: 25397472; PubMed Central PMCID: PMC4225394.
AÑO: 2014; IF: 5.09
|
25397472
|
Masiá M, Bernal E, Robledano C, Padilla S, López N, Martínez E, Gutiérrez F. Long-term effects of an intensive intervention in HIV-infected patients with moderate-high atherosclerotic cardiovascular risk. J Antimicrob Chemother. 2014 Nov;69(11):3051-6. doi: 10.1093/jac/dku269. Epub 2014 Jul 18. PubMed PMID: 25038306.
AÑO: 2014; IF: 5.071
|
|
Bernal E, Serrano J, Perez A, Valero S, Garcia E, Marín I, Muñoz A, Verdú JM, Vera C, Cano A. The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19723. doi: 10.7448/IAS.17.4.19723. PubMed PMID: 25397469; PubMed Central PMCID: PMC4225384.
AÑO: 2014; IF: 5.09
|
|
Romero-Sánchez MC, Alvarez-Ríos AI, Bernal-Morell E, Genebat M, Vera F, Benhnia MR, Bravo-Urbieta J, Galera-Peñaranda C, de Pablo-Bernal RS, Abad-Carrillo MA, Leal M, Ruiz-Mateos E; VIH-GEMUVIH Región de Murcia Study Group.. Maintenance of virologic efficacy and decrease in levels of ?2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy. Antiviral Res. 2014 Nov;111:26-32. doi: 10.1016/j.antiviral.2014.08.011. PubMed PMID: 25173576.
AÑO: 2014; IF: 3.938
|
|
Garcia F, Poveda E, Pérez-Elías MJ, Quero JH, Ribas MA, Martínez-Madrid OJ, Flores J, Crespo M, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestarán A, Paredes R. Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19520. doi: 10.7448/IAS.17.4.19520. PubMed PMID: 25394029; PubMed Central PMCID: PMC4224842.
AÑO: 2014; IF: 5.09
|